CD45单克隆抗体

英文名称 CD45(C2D1)
中文名称 CD45单克隆抗体
别 名 B220; CD 45; CD45; cd45 antigen; ec3.1.3.48; GP180; GP 180; L CA; LCA; L-CA; Leukocyte common antigen; LY5; Protein tyrosine phosphatase receptor type C; Protein tyrosine phosphatase receptor type c polypeptide; protein tyrosine phosphatase, receptor type, C; Receptor-type tyrosine-protein phosphatase C; PTPRC; PTPRC_HUMAN; SCID due to PTPRC deficiency; T200; T200 glycoprotein; T200 leukocyte common antigen; Human homolog of severe combined immunodeficiency due to PTPRC deficiency.
CD45单克隆抗体
说 明 书 0.1ml 0.2ml
研究领域 免疫学 神经生物学 信号转导 干细胞 转录调节因子 激酶和磷酸酶 细胞表面分子 细胞类型标志物 自然杀伤细胞 淋巴细胞 t-淋巴细胞 b-淋巴细胞
抗体来源 Mouse
克隆类型 Monoclonal
克 隆 号 C2D1
交叉反应 Human, Mouse, Rat, Cow,
产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 143kDa
细胞定位 细胞膜
性 状 Lyophilized or Liquid
浓 度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human CD45(1210-1251aa)
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
CD45单克隆抗体
产品介绍 background:
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus belongs to receptor type PTP. This gene is specifically expressed in hematopoietic cells. This PTP has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. This PTP also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. Four alternatively spliced transcripts variants of this gene, which encode distinct isoforms, have been reported. [provided by RefSeq, Jul 2008].

Function:
Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN. Dephosphorylates LYN, and thereby modulates LYN activity.

Subunit:
Binds GANAB and PRKCSH. Interacts with SKAP1. Interacts with DPP4; the interaction is enhanced in a interleukin-12-dependent manner in activated lymphocytes.

Subcellular Location:
Membrane; Single-pass type I membrane protein. Membrane raft. Note=Colocalized with DPP4 in membrane rafts.

Post-translational modifications:
Heavily N- and O-glycosylated.

DISEASE:
Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain.
CD45单克隆抗体
xy-0039R ADNP活性依赖的神经保护肽抗体
xy-6852R Alpha 1 Acid Glycoproteinα1酸性糖蛋白1/类粘蛋白1抗体
xy-7565R Alpha 1 acid glycoprotein 2α1酸性糖蛋白2抗体（类粘蛋白2）
xy-4610R phospho-AQP2(Ser264+261)磷酸化水通道蛋白2抗体
xy-1907R ATTY细胞酪氨酸转氨酶抗体
xy-1930R Vasopressin抗利尿激素/血管升压素/加压素/血管加压素抗体
xy-1960R ABCF1ATP结合盒蛋白家族GCN20F家族1抗体
xy-2405R AKR1B1醛糖还原酶抗体
xy-0945R Serum albumin人血清白蛋白抗体
xy-0935R Anthrax炭疽菌抗体（采用活疫苗制备）
xy-1531R ATF4活化转录因子4抗体
xy-0299R Adenylate Kinase 1腺苷酸激酶-1抗体
xy-1571R F-Actin纤维状肌动蛋白抗体
xy-1176R Agrin聚集蛋白抗体
xy-0037M AIF调亡诱导因子抗体
xy-0037R AIF调亡诱导因子抗体
xy-0097R ALK间变型淋巴瘤激酶抗体
xy-0840R AMACRα-甲基酰基辅酶A消旋酶抗体
xy-1562R Annexin A1膜粘连蛋白A1抗体
xy-3602R ATG1/ULK1自噬相关蛋白1抗体
xy-2199R beta Amyloid 1-16β淀粉样肽1-16/Aβ1-16 抗体
xy-1565R APCDD1腺瘤性息肉调节蛋白抗体
xy-1632R APPL1衔接因子蛋白含pH域蛋白1抗体
xy-2506R AQP7水通道蛋白-7抗体
xy-2532R ALT1/Alanine Transaminase谷丙氨酸氨基转移酶1抗体
xy-2936R ARHG7p21活化蛋白激酶ARHG7抗体
xy-6465R phospho-APE(Ser1417)磷酸化肌动蛋白结合蛋白Girdin抗体
xy-2640R ADO2-氨基乙硫醇双加氧酶抗体
xy-2097R Angiotensin II Type 1 Receptor血管紧张素Ⅱ-1型受体抗体
xy-10217R ADORA2B腺苷A2b受体/神经生长因子1受体抗体
xy-5850R ADAM19去整合素样金属蛋白酶19抗体
xy-5958R AF 4 protein原癌基因AF4蛋白抗体
xy-5861R ADAMTSL1整合素样金属蛋白酶与凝血酶样1蛋白抗体
xy-5862R ADAMTSL2整合素样金属蛋白酶与凝血酶样2蛋白抗体
xy-5863R ADAMTSL3整合素样金属蛋白酶与凝血酶样3蛋白抗体
xy-5852R ADAM20去整合素样金属蛋白酶20抗体
xy-5853R ADAM23去整合素样金属蛋白酶23抗体